{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-037043","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2023-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.363045+00:00","generated_at":"2026-06-08T21:46:41.764157+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Medifast Q3 revenue down 39.6% YoY to $235.9M; EPS $2.12 vs $3.27","bullets":["Revenue $235.9M (-39.6% YoY); net income $23.1M (-36.2% YoY); diluted EPS $2.12 vs $3.27.","Active earning Coaches 47,100 (-28.9% YoY); revenue per Coach $5,008 (-15.1%).","FY2023 guidance: revenue $1,050M-1,070M; diluted EPS $8.65-$9.55.","Cash & investments $157.8M, no debt; declared $1.65/share dividend payable Nov 7."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-037043","json":"https://secwatch.observer/filing/0001628280-23-037043.json","markdown":"https://secwatch.observer/filing/0001628280-23-037043.md","text":"https://secwatch.observer/filing/0001628280-23-037043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000162828023037043/0001628280-23-037043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000162828023037043/med-20231106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T21:46:41.764157+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1789485df00572f767454a19a1707916be8db45f","claim":"MEDIFAST INC reported third quarter ended September 30, 2023 results: revenue Revenue of $235.9 million, net income Net income of $23.1 million, EPS Earnings per diluted share (\"EPS\") of $2.12.","evidence_excerpt":"Medifast Announces Third Quarter 2023 Financial Results November 6, 2023 BALTIMORE--(BUSINESS WIRE)-- Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA®, today reported results for the third quarter ended September 30, 2023. Third Quarter 2023 • Revenue of $235.9 million, with revenue per active earning Coach of $5,008 • Independent active earning OPTA VIA Coaches of 47,100 • Net income of $23.1 million • Earnings per diluted share (\"EPS\") of $2.12","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828023037043/0001628280-23-037043-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"Revenue of $235.9 million"},{"label":"Net income","value":"Net income of $23.1 million"},{"label":"EPS","value":"Earnings per diluted share (\"EPS\") of $2.12"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}